BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:mibavademab readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of mibavademab\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07220772-147@assetmemo.bio
DTSTAMP:20261121T005715Z
DTSTART;VALUE=DATE:20270618
DTEND;VALUE=DATE:20270619
SUMMARY:mibavademab: Phase 3 readout est. (NCT07220772)
DESCRIPTION:mibavademab\, phase 3\, Obesity.\nStudy: A Study Evaluating Mib
 avademab Treatment of Obesity Due to Leptin (LEP) Gene Mutations in Childr
 en\, Adolescents and Adults\nEstimated primary completion: 18 June 2027. T
 his is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and 
 it can move.\nDrug page: https://assetmemo.bio/drug/mibavademab#upcoming-e
 vents\nRegistry record: https://clinicaltrials.gov/study/NCT07220772
URL:https://assetmemo.bio/drug/mibavademab#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07235917-147@assetmemo.bio
DTSTAMP:20261121T005715Z
DTSTART;VALUE=DATE:20280128
DTEND;VALUE=DATE:20280129
SUMMARY:mibavademab: Phase 2 readout est. (NCT07235917)
DESCRIPTION:mibavademab\, phase 2.\nStudy: A Study to Investigate Mibavadem
 ab in Adult Women With Functional Hypothalamic Amenorrhea\nEstimated prima
 ry completion: 28 January 2028. This is a ClinicalTrials.gov estimate\, no
 t a confirmed readout date\, and it can move.\nDrug page: https://assetmem
 o.bio/drug/mibavademab#upcoming-events\nRegistry record: https://clinicalt
 rials.gov/study/NCT07235917
URL:https://assetmemo.bio/drug/mibavademab#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07220785-147@assetmemo.bio
DTSTAMP:20261121T005715Z
DTSTART;VALUE=DATE:20280519
DTEND;VALUE=DATE:20280520
SUMMARY:mibavademab: Phase 3 readout est. (NCT07220785)
DESCRIPTION:mibavademab\, phase 3\, Generalized Lipodystrophy.\nStudy: Effi
 cacy and Safety of Mibavademab in Adult and Pediatric Patients With Genera
 lized Lipodystrophy\nEstimated primary completion: 19 May 2028. This is a 
 ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can mo
 ve.\nDrug page: https://assetmemo.bio/drug/mibavademab#upcoming-events\nRe
 gistry record: https://clinicaltrials.gov/study/NCT07220785
URL:https://assetmemo.bio/drug/mibavademab#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
